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Abstract We have used a two-hybrid approach to test various 
forms of Saccharomyces cerevisiae Ras2p for their ability to 
interact with the human guanine nucleotide exchange factor 
HGRF55. We have previously shown that a strong two-hybrid 
interaction is found between the HGRF55p and the dominant 
negative Ras2p(G22A) form of ras [Camus et al. (1995) 
Oncogene 11, 951-959). We show here that the substitution 
N123I which weakens the guanine nucleotide binding also 
promotes ras-GEF interaction. We demonstrate that the R80D 
substitution alone completely abolishes the interaction of 
Ras2p(G22A) with GEF, whereas substitutions at positions 81, 
82 and 73 have only small effects. Since residue 73 is involved in 
the response of ras to GEF, we propose that it plays a role in the 
conformational change induced by the GEF rather than in its 
binding. Those results emphasize the role of the a2 helix of the 
switch II region in the recognition of the GEF family. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Ras proteins act as molecular switches in several different 
signalling pathways. They are active when bound to GTP and 
switch their conformation to the inactive state when GTP is 
hydrolyzed to GDP [1,2]. The active form is recognized by 
different proteins in different organisms such as raf, ralGDS 
and phosphatidyl inositol-3 kinase (PI-3 kinase) in mamma-
lian cells or adenylyl cyclase in Saccharomyces cerevisiae. ln-
activation and activation of ras are controlled by two pro-
teins, a GTPase activating protein (GAP) and a guanine 
nucleotide exchange factor (GEF), respectively. Although 
the target of ras differs, the catalytic domains of its regulatory 
elements are conserved throughout evolution to the same ex-
tent as ras proteins. This conservation reflects the need for 
specific interactions between ras and its regulators. Indeed 
ras and the active domain of GEF have been functionally 
exchanged between yeast and mammalian cells [3-7]. 
In the past decade extensive work has been devoted to the 
analysis of the structure-function relationship of the ras pro-
teins. As a result, the effector domain of ras (switch I region) 
promoting the interaction with downstream targets and GAP 
has been well delimited [8-11]. In contrast, the portions of ras 
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involved in the interaction with the GEF are much less char-
acterized. Although genetic and biochemical analyses have 
identified several positions which are important for the re-
sponse to the GEF [12-17], those which are more directly 
involved in the interaction and those which relay the confor-
mational change remain to be defined. 
The best candidates for a specific ras-GEF interaction lie in 
the oe2-helix of the switch II region (amino acids 61-77 or 68-
84, for mammalian rasp21 and S. cerevisiae Ras2p respec-
tively). Substitutions at position 66 in the ras homologue 
let-60 of Caenorhabditis elegans, affects its normal function 
in vulval development [18]. If this mutation acts by uncou-
pling the GEF and ras, it is expected both to relieve a dom-
inant negative ras mutation sequestering the GEF and not to 
interfere with the dominant activation due to a ras oncogenic 
mutation. Indeed substitutions in p21ras at the same position 
lead to these phenotypes when assessed in NIH3T3 cells [12]. 
In contrast to wild type cells, the ratio of bound GTP on this 
ras mutant was not modified by overexpression of the yeast 
GEF Sdc25p, known to be active towards mammalian ras. 
Therefore the replacement of alanine by threonine or valine 
at position 66 (73 in Ras2p from S. cerevisiae) prevents, in 
vivo, the action of ras-GEF. The substitution G75S (in 
p21ras) was also shown to give similar phenotypes in vivo 
[12]. The replacement of the corresponding conserved glycine 
in S. cerevisiae Ras2p at position 82 by larger residues was 
shown to hinder the transition from inactive to active form 
[19]. In addition, amino acid substitutions in nearby residues 
at positions 80 and 81 were shown to impair the response to 
GEF in vitro on purified proteins [20]. Therefore the a2 helix, 
which is mobile and known to switch during the conforma-
tional change, appears to play a critical role in the response to 
GEF. 
In order to assess the involvement of these ras residues in 
the interaction of the ras protein with a GEF we have used 
the two-hybrid system that we have recently developed to test 
the interaction between mutant forms of the human exchange 
factor HGRF55 and the yeast Ras2p(G22A) protein [21]. The 
Ras2p was fused to the activation domain of Gal4p and we 
analyze here the effect of selected mutations of Ras2p on 
interaction with the GEF in a two-hybrid system. 
2. Materials and methods 
2.1. Strains 
The strains Y526 (MATa Agal4 AgatöO URA3::GALl-lacZ ura3 
his3 ade2 lys2 leu2 trpl ; kindly provided by M. Werner, CEA, France) 
and HF7c (MATa ura3-52, his3-200 lys2-801 ade2-101 trpl-901 leu2-3 
gal4-542 ga!80-538 LYS2:.GAL1-NIS3 URA3::(GAL4 17-mers)3-
CYCl-lacZ from the Clontech matchmaker kit) were used for the 
two-hybrid analysis with respectively the lacZ reporter gene and his-
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tidine prototrophy selection. The activity of all the Gal4-Ras2p and 
Gal4-Hgrf55p fusion proteins was tested respectively in the strains 
OL514 (Arasi Aras2 real; Georges Renault, personal communication) 
and OL97.1-11B (MATa cdc25-5 ura3 leu2 his3 his7; [22]) by comple-
mentation assays. 
2.2. Plasmici constructions 
The details for the constructions of the pGBT9-RAS2, pGBT9-
JMS2ak22 and pGAD424-C-.Bg//plasmids are described in [21]. Site 
directed mutagenesis by double-primer method ([25], see also modifi-
cations in [21]) was used to introduce appropriate mutations in the 
RAS2 wild type or RAS2!ila22 mutant context. The mutagenic primers 
designed to overlap the codon to be mutagenized are listed in Table 1. 
In most cases, two to three independent mutagenized clones were thus 
recovered and tested in the two-hybrid system. All mutations were 
checked by sequence analysis with automated DNA sequencing based 
on the dideoxy chain-termination method [23], using the ABI 373A 
sequencer. The double-strand DNAs were sequenced using the prism 
kit (Applied biosystem). During site mutagenesis of codon 82 (G to S 
substitution), a clone harboring an extra mutation (TTG->TCG; 
L30 -> S) along with the desired one was obtained. 
2.3. ß-Galactosidase assays 
ß-galactosidase activity was assayed for Y526 transformants either 
on filters or in liquid as previously described [1,3-5,12,19,21,24-32]. 
All assays were performed at least twice with several independent 
yeast transformants. 
2.4. Protein analysis 
Whole cell protein extracts were prepared as previously described 
[3,21,24-28,33]. Extracts were loaded on SDS-polyacrylamide gel [30] 
and immunoblotting was performed as previously described [34]. 
Ras2p protein antibodies were previously described [26]. 
3. Results and discussion 
3.1. Requirements for ras to interact with GEF 
In order to monitor the interaction between ras and its 
GEF we have used the system previously described [21]. 
Briefly, we have chosen to fuse the 281 carboxy-terminal res-
idues of the catalytic domain of the human exchange factor 
HGRF55p to the activation domain of Gal4p since this region 
is sufficient to suppress cdc25 mutations [6]. The entire open 
reading frame of the yeast RAS2 gene was fused to the DNA-
binding domain of the GAIA gene. The interaction of ras with 
GEF using the two-hybrid system has been reported previ-
ously by other groups using either a Acelp system [35] or a 
lexA based system [36]. As in other reports, the stronger in-
teraction was observed with a dominant negative mutation 
(Table 2). The Ras2p(G22A) is an altered form of ras which 
leads to a dominant negative phenotype in yeast [37]. This 
phenotype can be suppressed by overexpression of Cdc25p 
and has been interpreted as a sequestration of the major yeast 
GEF, the Cdc25p factor, by the Ras2p(G22A) protein. The 
two-hybrid results shown in Tables 2 and 3 confirm the much 
stronger interaction of this substituted form with a GEF. 
With the classical Gal4p-based two-hybrid system described 
here we get at least two orders of magnitude difference be-
tween the mutated and the wild type form of Ras2p (Table 2) 
as compared to the five-fold factor found in the Acelp system 
[35]. 
In contrast to others reports, we did not, however, detect 
the interaction with the wild type ras protein in our system 
although the two-hybrid interaction has also been tested with 
the more sensitive reporter gene HIS3 presents in the HF7c 
strain (Table 2 and data not shown). This result cannot be 
explained by the lack of either Ras2pwt or Hgrf55p proteins 
since the complementation assays performed in the appropri-
ate strains work (see Sections 2 and 3). This also cannot be 
assigned to the heterologous system that we use because the 
same results have been obtained using yeast Cdc25p and 
Ras2p proteins (Marco Geymonat, personal communication). 
Moreover, because of competition between the membrane 
localization signal of ras protein and the two-hybrid nuclear 
localization signal, the detection of the Ras-GEF interaction 
has required the inactivation of the carboxy-terminal CAAX 
box by a substitution of the conserved cysteine to arginine 
[21]. On the other hand, this result reveals that neither iso-
prenylation nor endoplasmic membrane association is strictly 
required for the Ras-GEF recognition, but we cannot exclude 
that membrane association enhances the interaction. 
3.2. Preferential binding of GEF to dominant negative alleles of 
ras 
As mentioned above, a preferential binding of the GEF to 
the dominant negative form Ras2p(G22A) has been observed 
in all three independent two-hybrid assays ([2,6,10,14-
17,23,34-39], and this work). In addition, we extend this ob-
servation to another substitution, Ras2p(N123I), which also 
leads to a dominant negative form of ras (Table 2). It has 
been reported that two substitutions in the guanine nucleotide 
pocket NKXD of v-H-ras [27], N116I and K117E, allow the 
formation of a stable complex with the GEF domain of 
Sdc25p [29]. These modifications result in a reduced affinity 
for guanine nucleotide and confirm that empty forms of ras 
display a stronger affinity for the GEF [31]. In our experi-
ments we find that only the N123I (N116I) substitution pro-
motes a strong two-hybrid interaction (Table 2) whereas the 
Ras2p(K124E) (K117E in v-H-ras) behaves as the wild type 
and is even able to complement the deletion of RAS genes 
(Fig. 1 and see Section 3.5). 
This difference can be explained by the differential require-
ment for GTP to promote the dissociation of the complex ras-
GEF which was measured to be 0.08 mM and 10 mM for the 
p21(K117E) and p21(N116I) respectively [29]. With a cellu-
lar concentration in the millimolar range, only the 
Ras2p(K124E)-GEF complex is expected to be displaced by 
GTP. Thus in vivo, the Ras2p(K124E) protein no longer 
Table 1 
Ohgonucleotides used for the site-directed mutagenesis of RAS2 or RAS2 
RAS2/olil6 
RAS2/olil7 
RAS2/olil8 
RAS2/olil9z 
RAS2/oli20 
RAS2/oli21 
RAS2/oli22 
(A73^T) 
(A73^V) 
(R80^D) 
(N81^D) 
(G82^S) 
(N123^I) 
(K124^E) 
°GAA TAC TCT aCT ATG AGG GAA Cz 
8GAA TAC TCT gtT ATG AGG GAA C2 
*C ATG CGC AAC tcC GAA GGA TTC Cz0° 
8GTT GTT GGT AtC AAA TCT GAT TTA G31 
The nucleotides modified by mutagenesis are in lower case. The corresponding codons are underlined and the amino acid substitutions are indicated 
in parentheses. The positions of the ohgonucleotides on the RAS2 sequence are indicated using the first ATG as position one. 
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forms a stable complex with GEF as observed in the two-
hybrid assay (Table 2). Moreover, the different behavior ob-
served here between these N116I and K117E substitutions 
argues in favor of the selectivity of this assay to follow the 
Ras-GEF interaction. 
3.3. Substitutions in the a2 helix of ras differentially affect the 
interaction with the GEF 
Second mutations have been introduced in Ras2p(G22A) to 
test their effect in the two-hybrid interaction assay. We have 
chosen to change positions 73, 80, 81 and 82 which are known 
to be involved in the response to GEF [12,13,17,20]. 
3.3.1. Position 73 in Ras2p is not essential for the two-hybrid 
interaction. We have chosen to analyze substitutions at posi-
tion 66 (73 in yeast Ras2p), which was considered the best 
candidate for ras-GEF interaction since its substitution leads 
to a stable protein that affects the mammalian cells response 
to GEF, abolishes the sequestering effect of dominant nega-
tive mutation at position 17 in p21ras but does not alter the 
activated conformation of an oncogenic ras protein [12]. As 
shown in Table 3, neither A to T nor A to V substitution at 
position 73 in yeast Ras2p eliminates the two-hybrid interac-
tion. The A73T substitution has no detectable effect on the 
GEF interaction and the A73V substitution only reduces the 
level of ß-galactosidase by a factor of two. This result shows 
that this position is not a key determinant for the establish-
ment of an interaction with the GEF in the two-hybrid system 
used here. The greater effect observed with the A73V substi-
tution as compared to the A73T substitution could still indi-
cate some interference with the GEF interaction due to steric 
hindrance. However, the two-fold effect measured in the two-
hybrid assay appears too small to account for the biological 
effects reported for these substitutions in vivo. Therefore it 
seems more likely that the alanine at position 73 (66 in 
p21ras) is required for the proper change in ras conformation 
induced by the binding of the GEF rather than for the bind-
ing itself. Indeed, the introduction of a larger residue in the 
switch II region might block the conformational change re-
quired for ras activation in response to GEF. 
3.3.2. Position 80 in Ras2p has an essential role for ras GEF 
interaction. The R80D substitution has a dramatic effect in 
preventing any activation of the GALI promoter (Table 3). 
This result is not due to the absence or to the degradation of 
the corresponding protein in yeast, since for all ras mutant 
tested here, equal levels of protein were detected by Western 
blotting (not shown). This result confirms the importance of 
position 80 in ras for the action of a GEF. It could suggest 
Table 2 
Two-hybrid interaction of various single ras mutant forms with gua-
nine exchange factor Hgrf55p 
Tested interaction ß-Galactosidase activity 
HGRF55p/Ras2p(wild type) 0.1 
HGRF55p/Ras2p(G22A) 9.7 
HGRF55p/Ras2p(N123I) 10 
HGRF55p/Ras2p(K124E) 0.1 
HGRF55p/Ras2p(R80D) 0.1 
HGRF55p/Ras2p(N81D) 0.1 
HGRF55p/Ras2p(G82S) 0.1 
The ß-galactosidase activity is expressed in nmol of o-nitrophenyl-ß-D-
galactoside hydrolysed per minute and per mg of protein. The value 
of 0.1 corresponds to the background level. A value of 1000 is ob-
tained for the entire Gal4p activator itself. 
Fig. 1. Complementation assays in strain OL514 (Arasi Aras2 rea). 
The plasmids used in the two-hybrid system harboring a Ras2p wild 
type or mutant forms were tested for complementation in strain 
OL514. Four independent yeast transformants first grown on selec-
tive medium containing 5 mM cAMP were further tested on rich 
medium with or without cAMP. Growth was carried out at 30°C 
for 3 days. 
that this arginine residue is directly involved in the interaction 
by its positive charge at the surface of the molecule. It is 
interesting to note that with the same two-hybrid system, 
the only substitution found in the GEF to be able to disrupt 
the interaction with ras was the change of an arginine to an 
alanine [21]. Moreover, it has been found that with a reverse 
ion pair change at the positively charged residue R1374 in 
yeast Cdc25p and the negatively charged residue E63 in H-
ras, it was possible to partially suppress the non-functional 
state of each mutant protein [38]. Taking together, these re-
sults reinforce the possibility that ras-GEF interaction is con-
trolled by a salt bridge between the two proteins. 
In contrast to the effect of the substitution at position 80, 
substitutions at non-charged positions N81 or G82 show only 
mild effects on the ras-GEF interaction (Table 3). In previous 
results obtained [17], it was difficult to appreciate the contri-
bution of a substitution at position 81 as compared to posi-
tion 80 since they were both associated. We demonstrate here 
that the single substitution at position 81 does not signifi-
cantly change the ras-GEF interaction. However, this muta-
tion affects the activity of ras as shown in the complementa-
tion assay (Fig. 1). Position 82, which is important for the 
transition from the inactive to the active state of ras [19], does 
not appear to be directly involved in the interaction with the 
GEF nor in the biological activity of ras (Fig. 1). 
3.4. Substitution at position 30 might alter ras nudeotide bound 
state 
In the course of G82S mutagenesis we have obtained a 
clone harboring an additional mutation which leads to the 
substitution L30S (see Section 2). This Ras2p(G22A; L30S; 
G82S) mutant form has been introduced in the two-hybrid 
assay. The ß-galactosidase activity detected is 10-fold smaller 
than that measured for the Ras2p(G22A; G82S) form (Table 
3). This L30S substitution might be expected to reduce the 
GTPase activity leading to an accumulation of the ras.GTP 
bound form that no longer interacts with GEF. Recently, L23 
in rasp21 (equivalent to L30 in Ras2p) has been shown to be 
involved in strong contact with the strictly conserved F156 
S. Hermann-Le Denmat, M. JacquetlFEBS Letters 403 (1997) 95-99 
Table 3 
Two-hybrid interaction of Ras2p(G22A) associated mutant forms with guanine exchange factor HGRF55p 
Tested interaction ß-Galactosidase activity" Ratio (%)b 
HGRF55p/Ras2p(G22A) 
HGRF55p/Ras2p(G22A;A73T) 
HGRF55p/Ras2p(G22A;A73V) 
HGRF55p/Ras2p(G22A;R80D) 
HGRF55p/Ras2p(G22A ;N81D) 
HGRF55p/Ras2p(G22A;G82S) 
HGRF55p/Ras2p(G22A;L30S;G82S) 
9.7 
10.3 
4.7 
0.1 
11 
7.8 
0.85 
100 
106 
48 
<1 
113 
;.7 
aß-Galactosidase activity is expressed in nmol of o-nitrophenyl-ß-D-galactoside hydrolysed per minute and per mg of protein. 
b ß-Galactosidase activity is expressed as the percentage of the remaining activity detected for a given Ras2p double or triple mutant form relative to 
the activity measured for Ras2p(G22A). 
residue (F149 in yeast Ras2 protein) [39]. This conserved phe-
nylalanine residue also participates in the GDP/GTP switch 
since a F149L substitution leads to increased levels of ras-
GTP in vivo [39]. According to these results, it could be sug-
gested that the L30S mutation may alter the ras nucleotide 
binding state and thus modify the ras-GEF interaction as 
observed with the two-hybrid assay. However, we cannot ex-
clude that the folding of the Ras2p(G22A; L30S; G82S) mu-
tant protein is so altered that the ras-GEF interaction is 
greatly affected but not abolished. 
3.5. Complementation assay of the ras constructs 
We have checked the ability of all ras constructions to 
complement a yeast strain deleted from the RASI and 
RAS2 genes (Fig. 1). Strain OL514 (Arasi Aras2 real) con-
tains the rcallpdel mutation which affects the phosphodiester-
ase involved in the cyclic adenosine 3',5'-monophosphate 
(cAMP) degradation [40]. The lethality caused by rasi and 
ras2 deletions can thus be rescued by the addition of cAMP 
in the growth medium. When a given RAS gene is introduced, 
the transformed strain will grow without addition of exoge-
nous cAMP only if the protein is functional. All ras mutants 
were tested in that strain. We have found that the wild type 
RAS2 and the two mutants ras2G82S and ras2KU4E were able 
to complement the defect of RAS (Fig. 1). This result indi-
cates that the fusion of the Ras2p protein to the activation 
domain of Gal4p does not impair its ability to interact with its 
target and activator. In addition it shows that the CAAX box 
is not essential for suppression of the growth defect in yeast, 
at least when the corresponding ras protein is overexpressed. 
The lack of complementation exhibited by the other con-
structs suggests that they are not or much less functional. As 
previously mentioned, it is not due to the degradation of the 
fusion proteins since they are all found in similar amounts in 
Western blotting (not shown). This absence of growth is ex-
pected for the dominant negative forms Ras2p(K123E) and 
Ras2p(G22A). Moreover, the dominant negative phenotype 
associated with the single G22A substitution cannot be res-
cued by any of the combined second mutation (Fig. 1), not 
even by the R80D one which strongly inhibited ras-GEF in-
teraction measured by the two-hybrid assay and thus relieves 
the sequestration effect of the G22A substitution (Table 3). 
The complementation assay also confirms that substitutions at 
positions 80 and 81 lead to inactive forms as already observed 
[20]. 
4. Conclusion 
Our results emphasize the importance of the a2 helix in the 
response of ras to the GEF. The orientation of this helix has 
been proposed to change between the GDP and the GTP form 
[1,2,6,9,10,13-16,20,23,32,34,35,37-39]. Therefore its involve-
ment in the interaction with GEF could be the basis for a 
specificity in the recognition of the ras.GDP bound form by 
a guanine exchange factor. The fact that in vitro, GEF are 
also able to release GTP suggests the existence of other sites 
of interaction with ras [24]. The region 103-108 of ras, which 
does not change during the transition from the GDP to the 
GTP state, could be one of these since it has been shown that 
substitutions in that region abolished the response to Cdc25p 
[15,16]. 
Among the various positions required for the GEF effect on 
ras, only one was found to be critical in the two-hybrid inter-
action. Although we cannot exclude that the change in con-
formation induced by substitution G22A slightly modifies the 
ras-GEF interaction, we can postulate that residue 80 in ras2p 
is the most directly involved amino acid in this contact. The 
substitutions in position 73 themselves may just prevent the 
change in conformation induced by the interaction and re-
quired to form the active state of ras. 
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